Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(33%)
Results Posted
50%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
2
33%
Ph phase_1
3
50%
Ph phase_4
1
17%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (50.0%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

unknown117%
completed233%
recruiting117%
active_not_recruiting117%
terminated117%

Recent Activity

2 active trials
Showing 5 of 6
recruitingnot_applicable

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

NCT06382818
active_not_recruitingphase_1

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

NCT04280536
completedphase_1

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

NCT06640920
terminatednot_applicable

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

NCT03189381
completedphase_1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

NCT04389775
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06382818Not Applicable

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Recruiting
NCT04280536Phase 1

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

Active Not Recruiting
NCT06640920Phase 1

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

Completed
NCT03189381Not Applicable

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

Terminated
NCT04389775Phase 1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

Completed
NCT02910375Phase 4

Golimumab Dried Blood Spot Analysis

Unknown

All 6 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
6